Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines clinical trials

Explore recruiting patients with high risk locally advanced non metastatic node negative single or multifocal basal cell carcinoma bcc or cutaneous squamous cell carcinoma cscc amenable to intratumoral injection not eligible to surgery or radiation therapy according to the evaluation of a local interdisciplinary tumor board or who refuse surgery or radiation therapy and for whom a histological evaluation is available according to international guidelines clinical trials.

Also recruiting in Europe

Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines trials by city

Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Toronto Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Vancouver Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Montreal Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Calgary Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Edmonton Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Ottawa Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Winnipeg Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Quebec City Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Hamilton Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Kitchener Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in London Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Halifax Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in New York Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Los Angeles Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Chicago Patients With High Risk Locally Advanced Non Metastatic Node Negative Single Or Multifocal Basal Cell Carcinoma Bcc Or Cutaneous Squamous Cell Carcinoma Cscc Amenable To Intratumoral Injection Not Eligible To Surgery Or Radiation Therapy According To The Evaluation Of A Local Interdisciplinary Tumor Board Or Who Refuse Surgery Or Radiation Therapy And For Whom A Histological Evaluation Is Available According To International Guidelines in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease